Abstract
Nasopharyngeal swabs are critical to the diagnosis of respiratory infections including COVID-19, but collection techniques vary. We compared two recommended nasopharyngeal swab collection techniques in adult volunteers and found that swab rotation following nasopharyngeal contact did not recover additional nucleic acid (as measured by human DNA/RNA copy number). Rotation was also less tolerable for participants. Notably, both discomfort and nucleic acid recovery were significantly higher in Asians, consistent with nasal anatomy differences. Our results suggest that it is unnecessary to rotate the swab in place following contact with the nasopharynx, and reveal that procedural discomfort levels can differ by ethnicity.
summary Nasopharyngeal swabs are critical to COVID-19 diagnostics, but collection techniques vary. Comparison of two collection techniques revealed that swab rotation did not recover more nucleic acid and was more uncomfortable. Discomfort and biological material recovery also varied by participant ethnicity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a Genome BC COVID-19 Rapid Response grant (grant number: COV-115) awarded to CFL and ZLB as co-PIs. NNK holds a Vanier Canada Graduate Scholarship from the Canadian Institutes for Health Research (CIHR). AS holds a CIHR Frederick Banting and Charles Best Doctoral Award. ZLB holds a Scholar Award from the Michael Smith Foundation for Health Research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Providence Health Care/University of British Columbia and Simon Fraser University Research Ethics Boards. All participants provided written informed consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Sources of Financial support This work was supported by a Genome BC COVID-19 Rapid Response grant (grant number: COV-115) awarded to CFL and ZLB as co-PIs. NNK holds a Vanier Canada Graduate Scholarship from the Canadian Institutes for Health Research (CIHR). AS holds a CIHR Frederick Banting and Charles Best Doctoral Award. ZLB holds a Scholar Award from the Michael Smith Foundation for Health Research.
This work has not been previously presented at any conference or meeting.
Data Availability
All data described in this manuscript are available upon reasonable request to the corresponding author.
